Pingli Mo
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 3
- Cancer-related Molecular Pathways 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Co-authors
- Chundong Yu (25 shared papers)Wengang Li (10 shared papers)Kesong Peng (8 shared papers)Ming Li (10 shared papers)Qiang Chen (10 shared papers)Hongbo Wang (2 shared papers)Chunhong Yan (2 shared papers)Jianming Xu (9 shared papers)
- Journals
- Oncogene (5 papers)Journal of Biological Chemistry (5 papers)Cell & Bioscience (4 papers)Frontiers in Pharmacology (2 papers)Journal of Pharmaceutical Analysis (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Pingli Mo
33 papers receiving 703 citations
Peers
Comparison fields: 5 of 63
- Oncology 147
- Cancer Research 76
- Molecular Biology 346
- Drug Discovery 1
- Complementary and alternative medicine 33
Countries citing papers authored by Pingli Mo
This map shows the geographic impact of Pingli Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingli Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingli Mo more than expected).
Fields of papers citing papers by Pingli Mo
This network shows the impact of papers produced by Pingli Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingli Mo. The network helps show where Pingli Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Pingli Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 87 | |
| 2 | 2018 | 55 | |
| 3 | 2010 | 49 | |
| 4 | 2010 | 49 | |
| 5 | 2016 | 44 | |
| 6 | 2020 | 36 | |
| 7 | 2020 | 33 | |
| 8 | 2015 | 31 | |
| 9 | 2020 | 31 | |
| 10 | 2014 | 29 | |
| 11 | 2020 | 28 | |
| 12 | 2022 | 28 | |
| 13 | 2006 | 24 | |
| 14 | 2022 | 24 | |
| 15 | 2022 | 20 | |
| 16 | 2012 | 18 | |
| 17 | 2023 | 16 | |
| 18 | 2018 | 15 | |
| 19 | 2024 | 15 | |
| 20 | 2017 | 14 |
About Pingli Mo
Pingli Mo is a scholar working on Oncology, Hepatology, Molecular Biology, Immunology and Cancer Research, having authored 34 papers that have together received 715 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune Response and Inflammation (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related Molecular Pathways (3 papers), Mast cells and histamine (2 papers) and Escherichia coli research studies (2 papers). The work is most often cited by research in Oncology (147 citations), Cancer Research (76 citations), Molecular Biology (346 citations), Drug Discovery (1 citation) and Complementary and alternative medicine (33 citations). Pingli Mo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chundong Yu, Wengang Li, Kesong Peng, Ming Li, Qiang Chen, Hongbo Wang, Chunhong Yan, Jianming Xu, Zhangwei Tong and Shumei Ren. Their work appears in journals such as Oncogene, Journal of Biological Chemistry, Cell & Bioscience, Frontiers in Pharmacology and Journal of Pharmaceutical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.